US5821088A
(en)
*
|
1990-05-11 |
1998-10-13 |
Siga Pharmaceuticals, Inc. |
Use of gram-positive bacteria to express recombinant proteins
|
US5593877A
(en)
*
|
1993-03-11 |
1997-01-14 |
The Rockefeller University |
Nucleic acid and recombinant production of vespid venom hyaluronidase
|
AU1838495A
(en)
*
|
1994-02-03 |
1995-08-21 |
Scripps Research Institute, The |
Method for using tobacco mosaic virus to overproduce peptides and proteins
|
JP3637087B2
(ja)
*
|
1994-11-28 |
2005-04-06 |
和男 鈴木 |
新規な白血球活性化因子
|
US5795587A
(en)
*
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
JPH11506424A
(ja)
*
|
1995-03-24 |
1999-06-08 |
オフィディアン ファーマシューティカルズ インコーポレーテッド |
ベロ毒素産生大腸菌に対する治療
|
JPH11505421A
(ja)
|
1995-05-11 |
1999-05-21 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
ヒトウリジンジホスフェートガラクトース−4−エピメラーゼ
|
US20030069173A1
(en)
*
|
1998-03-16 |
2003-04-10 |
Life Technologies, Inc. |
Peptide-enhanced transfections
|
US6051429A
(en)
|
1995-06-07 |
2000-04-18 |
Life Technologies, Inc. |
Peptide-enhanced cationic lipid transfections
|
AT404838B
(de)
*
|
1995-11-24 |
1999-03-25 |
Immuno Ag |
Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
|
US5935824A
(en)
*
|
1996-01-31 |
1999-08-10 |
Technologene, Inc. |
Protein expression system
|
JP2000510332A
(ja)
*
|
1996-04-19 |
2000-08-15 |
ヘンリー エム.ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン |
インチミンを単独で、または1以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法
|
US20030040038A1
(en)
*
|
1997-08-22 |
2003-02-27 |
Steven F. Dowdy |
Inducible regulatory system and use thereof
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
JP2002505077A
(ja)
|
1997-12-10 |
2002-02-19 |
ワシントン大学 |
抗病原体システムおよびその使用方法
|
WO1999040434A1
(en)
|
1998-02-04 |
1999-08-12 |
Invitrogen Corporation |
Microarrays and uses therefor
|
US6506595B2
(en)
|
1998-03-31 |
2003-01-14 |
Itoham Foods Inc. |
DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
|
US20030138973A1
(en)
*
|
1998-07-14 |
2003-07-24 |
Peter Wagner |
Microdevices for screening biomolecules
|
US6897073B2
(en)
*
|
1998-07-14 |
2005-05-24 |
Zyomyx, Inc. |
Non-specific binding resistant protein arrays and methods for making the same
|
US6576478B1
(en)
*
|
1998-07-14 |
2003-06-10 |
Zyomyx, Inc. |
Microdevices for high-throughput screening of biomolecules
|
US6406921B1
(en)
*
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
US6913749B2
(en)
*
|
1998-11-02 |
2005-07-05 |
Resistentia Pharmaceuticals Ab |
Immunogenic polypeptides for inducing anti-self IgE responses
|
EP1129064B1
(de)
|
1998-11-12 |
2008-01-09 |
Invitrogen Corporation |
Transportreagentien
|
US7262005B1
(en)
|
2000-02-04 |
2007-08-28 |
Aurora Biosciences Corporation |
Methods of protein destabilization and uses thereof
|
IL152634A0
(en)
*
|
2000-05-04 |
2003-06-24 |
Univ Yale |
High density protein arrays for screening of protein activity
|
US7494786B2
(en)
*
|
2000-06-15 |
2009-02-24 |
Yale University |
Mutant proteinase with reduced self-cleavage activity and method of purification
|
WO2003089604A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Genencor International, Inc. |
Methods of creating modified promoters resulting in varying levels of gene expression
|
US7825227B2
(en)
*
|
2002-05-09 |
2010-11-02 |
Prolexys Pharmaceuticals, Inc. |
Method for purification of a protein complex and identification of its components
|
EP1587908A4
(de)
*
|
2003-01-09 |
2008-02-20 |
Invitrogen Corp |
Zelluläre zuführung und aktivierung von polypeptid-nukleinsäurekomplexen
|
JP4850698B2
(ja)
|
2003-04-25 |
2012-01-11 |
ノース・キャロライナ・ステイト・ユニヴァーシティ |
細胞表面タンパク質相同体をコードするアシドフィルス菌核酸配列及びその使用
|
EP1651750B1
(de)
|
2003-06-23 |
2011-04-06 |
North Carolina State University |
Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
|
WO2005074524A2
(en)
*
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human interferon polypeptides and their uses
|
AU2005319099B2
(en)
*
|
2004-02-02 |
2010-09-16 |
Ambrx, Inc. |
Modified human growth hormone
|
US7459289B2
(en)
|
2004-03-08 |
2008-12-02 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
|
KR101699142B1
(ko)
*
|
2004-06-18 |
2017-01-23 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
EP1771573A4
(de)
*
|
2004-07-21 |
2009-02-18 |
Ambrx Inc |
Nichtnatürliche kodierte aminosäuren verwendende biosynthetische polypeptide
|
MX2007007587A
(es)
*
|
2004-12-22 |
2007-12-11 |
Ambrx Inc |
Formulaciones de la hormona del crecimiento humano que comprenden un aminoacido codificado de manera no natural.
|
CN103290084A
(zh)
|
2004-12-22 |
2013-09-11 |
Ambrx公司 |
表达和纯化重组人类生长激素的方法
|
JP4990792B2
(ja)
*
|
2004-12-22 |
2012-08-01 |
アンブレツクス・インコーポレイテツド |
アミノアシル−tRNAシンテターゼの組成物およびこの使用
|
JP5362349B2
(ja)
|
2005-04-15 |
2013-12-11 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
タンパク質を精製する方法
|
BRPI0610609A2
(pt)
|
2005-04-15 |
2010-07-06 |
Univ North Carolina State |
métodos e composições para modular a adesão e toleráncia ao estresse em bactérias
|
JP2008541769A
(ja)
*
|
2005-06-03 |
2008-11-27 |
アンブレツクス・インコーポレイテツド |
改善されたヒトインターフェロン分子及びそれらの使用
|
EP2484774A3
(de)
*
|
2005-07-21 |
2012-11-14 |
Abbott Laboratories |
Mehrfache Genexpression mit sORF-Konstrukten und Verfahren mit Polyproteinen, Pro-Proteinen und Proteolyse
|
MX2008002149A
(es)
*
|
2005-08-18 |
2008-04-22 |
Ambrx Inc |
Composiciones de arnt y sus usos.
|
RS51998B
(en)
*
|
2005-11-08 |
2012-04-30 |
Ambrx Inc. |
ACCELERATORS FOR MODIFICATION OF NON-NATURAL AMINO ACIDS AND NON-NATURAL AMINO ACID POLYPEPTIDES
|
CA2626522A1
(en)
*
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
SG170116A1
(en)
*
|
2005-12-14 |
2011-04-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
JP5399906B2
(ja)
*
|
2006-09-08 |
2014-01-29 |
アンブルックス,インコーポレイテッド |
脊椎動物細胞用のハイブリッドサプレッサーtrna
|
CN101511856B
(zh)
*
|
2006-09-08 |
2016-01-20 |
Ambrx公司 |
脊椎动物细胞中抑制因子trna的转录
|
EP2076527B1
(de)
*
|
2006-10-13 |
2014-12-10 |
Novo Nordisk Health Care AG |
Prozessierende enzyme fusioniert mit basischen proteinanhängern
|
CN107501407B
(zh)
|
2007-03-30 |
2022-03-18 |
Ambrx公司 |
经修饰fgf-21多肽和其用途
|
AU2008247815B2
(en)
*
|
2007-05-02 |
2012-09-06 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
NZ603812A
(en)
*
|
2007-11-20 |
2014-06-27 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
NZ620606A
(en)
|
2008-02-08 |
2015-08-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
PE20110426A1
(es)
*
|
2008-07-23 |
2011-07-01 |
Ambrx Inc |
Polipeptidos g-csf bovinos modificados
|
CN107022020A
(zh)
|
2008-09-26 |
2017-08-08 |
Ambrx公司 |
修饰的动物促红细胞生成素多肽和其用途
|
CN102224238B
(zh)
|
2008-09-26 |
2015-06-10 |
Ambrx公司 |
非天然氨基酸复制依赖性微生物和疫苗
|
WO2010112193A1
(en)
|
2009-04-02 |
2010-10-07 |
Roche Glycart Ag |
Multispecific antibodies comprising full length antibodies and single chain fab fragments
|
CN102712696A
(zh)
|
2009-09-16 |
2012-10-03 |
弗·哈夫曼-拉罗切有限公司 |
包含卷曲螺旋和/或系链的蛋白质复合体及其用途
|
RU2012122240A
(ru)
*
|
2009-10-30 |
2013-12-10 |
Эбботт Лэборетриз |
Конструкции sorf и экспрессия нескольких генов
|
AR080793A1
(es)
|
2010-03-26 |
2012-05-09 |
Roche Glycart Ag |
Anticuerpos biespecificos
|
RS59193B1
(sr)
|
2010-08-17 |
2019-10-31 |
Ambrx Inc |
Modifikovani polipeptidi relaksina i njihova primena
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
RU2013110875A
(ru)
|
2010-08-24 |
2014-09-27 |
Ф.Хоффманн-Ля Рош Аг |
БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА, СОДЕРЖАЩИЕ СТАБИЛИЗИРОВАННЫЙ ДИСУЛЬФИДОМ ФРАГМЕНТ Fv
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
JP5766296B2
(ja)
|
2010-12-23 |
2015-08-19 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
|
BR112014019579A2
(pt)
|
2012-02-10 |
2019-10-15 |
Genentech, Inc |
Anticorpo de cadeia única, polinucleotídeo, vetor, célula hospedeira, método de produção de um anticorpo de cadeia única, heteromultímero e método de produção do heteromultímero
|
WO2014001325A1
(en)
|
2012-06-27 |
2014-01-03 |
F. Hoffmann-La Roche Ag |
Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
|
BR112014032193A2
(pt)
|
2012-06-27 |
2017-06-27 |
Hoffmann La Roche |
métodos de produção de anticorpos biespecíficos e de determinação de combinação, anticorpo biespecífico, formulação e uso de anticorpo biespecífico
|
KR101536963B1
(ko)
*
|
2013-09-17 |
2015-07-16 |
재단법인 전주생물소재연구소 |
식물에서 tev 프로테아제를 대량생산하는 방법 및 상기 방법에 의해 제조된 tev 프로테아제
|
EP3169310A1
(de)
|
2014-07-15 |
2017-05-24 |
Life Technologies Corporation |
Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen
|
PT3412302T
(pt)
|
2014-10-24 |
2021-06-09 |
Bristol Myers Squibb Co |
Polipéptidos de fgf-21 modificados e utilizações dos mesmos
|
WO2016087416A1
(en)
|
2014-12-03 |
2016-06-09 |
F. Hoffmann-La Roche Ag |
Multispecific antibodies
|
CN110637027A
(zh)
|
2017-02-08 |
2019-12-31 |
百时美施贵宝公司 |
包含药代动力学增强子的修饰的松弛素多肽及其用途
|
WO2023168234A1
(en)
|
2022-03-01 |
2023-09-07 |
Danisco Us Inc. |
Enzymes and enzyme compositions for cleaning
|
CN116144689A
(zh)
*
|
2023-03-06 |
2023-05-23 |
优睿赛思(武汉)生物科技有限公司 |
重组猫血清淀粉样蛋白a的表达载体、宿主菌及其制备方法
|